Axe Compute EBITDA 2012-2026 | AGPU
Axe Compute ebitda from 2012 to 2026. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Axe Compute Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $-180 |
| 2024 | $-10 |
| 2023 | $-11 |
| 2022 | $-21 |
| 2021 | $-16 |
| 2020 | $-23 |
| 2019 | $-11 |
| 2018 | $-7 |
| 2017 | $-6 |
| 2016 | $-6 |
| 2015 | $-4 |
| 2014 | $-6 |
| 2013 | $-8 |
| 2012 | $-7 |
| 2011 | $-4 |
|
Axe Compute Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-8 |
| 2025-12-31 | $-173 |
| 2025-09-30 | $-3 |
| 2025-06-30 | $-2 |
| 2025-03-31 | $-2 |
| 2024-12-31 | $-3 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-12 |
| 2022-09-30 | $3 |
| 2022-06-30 | $-10 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-8 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-12 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-3 |
| 2019-06-30 | $-4 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $0 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.022B | $0.000B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |